Evaluation of a novel nanocrystalline hydroxyapatite paste Ostim<sup>® </sup>in comparison to Alpha-BSM<sup>® </sup>- more bone ingrowth inside the implanted material with Ostim<sup>® </sup>compared to Alpha BSM<sup>®</sup>
<p>Abstract</p> <p>Background</p> <p>The purpose of this study was to evaluate the performance a newly developed nanocrystalline hydroxyapatite, OSTIM<sup>® </sup>following functional implantation in femoral sites in thirty-eight sheep for 1, 2 or 3 months....
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-12-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/10/164 |